chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Urticaria
Clinical narrative: Hives; Short of breath; This spontaneous case was reported by a health care professional and describes the occurrence of DYSPNOEA (Short of breath) and URTICARIA (Hives) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced DYSPNOEA (Short of breath). On 27-Feb-2021, the patient experienced URTICARIA (Hives). The patient was treated with PREDNISONE at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Short of breath) outcome was unknown and URTICARIA (Hives) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was prescribed with steroids and advised not to get the second dose. No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up information received on 30-APR-2021 contains no significant information. On 21-Jun-2021: Followup information included additional treatment medications and action taken was updated.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Limb injury, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: lump under the arm after 2 days-Severe
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: non stop diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (non stop diarrhea) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Diarrhea (the patient said that he had same diarrhea a few months ago and asked about loperamide 2mg.).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DIARRHOEA (non stop diarrhea). On 03-Mar-2021, DIARRHOEA (non stop diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details was not reported by the reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching all over; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PRURITUS (Itching all over). At the time of the report, PRURITUS (Itching all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included lotions and anti allergy medicines. No concomitant medications provided.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and TREMOR (shakes) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.  The patient's past medical history included COVID-19 (Tested + (positive) for COVID19 on 25thJAN2021.) on 25-Jan-2021.  On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PYREXIA (fever) and TREMOR (shakes). At the time of the report, PYREXIA (fever) and TREMOR (shakes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.   No treatment details was reported.   This case was linked to MOD-2021-031753 (Linked Report).; Sender's Comments:  MOD-2021-031753:Husband case
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dry mouth, Fall, Fatigue, Injection site pain
Clinical narrative: Dry mouth; taste isn't the same after first dose; still feeling dizzy; PAIN IN NECK, SHOULDER AND LOWER PACK; VERY EXHAUSTED AND FELT VERY FATIGUE AND HAD TO TAKE A NAP; LOCAL PAIN IN THE INJECTION SITE; very DIZZY; FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR; SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very DIZZY), FALL (FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR), PHOTOPHOBIA (SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES), DRY MOUTH (Dry mouth) and TASTE DISORDER (taste isn't the same after first dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Radiation therapy. Concurrent medical conditions included Penicillin allergy and Allergy to chemicals. Concomitant products included HYOSCYAMINE SULFATE (NULEV [HYOSCYAMINE SULFATE]) for Spasms, GLUCOSAMINE, CHONDROITIN, NAPROXEN SODIUM (ALEVE), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DIZZINESS (very DIZZY), FALL (FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR), PHOTOPHOBIA (SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES), PAIN (PAIN IN NECK, SHOULDER AND LOWER PACK), FATIGUE (VERY EXHAUSTED AND FELT VERY FATIGUE AND HAD TO TAKE A NAP) and INJECTION SITE PAIN (LOCAL PAIN IN THE INJECTION SITE). On an unknown date, the patient experienced DRY MOUTH (Dry mouth), TASTE DISORDER (taste isn't the same after first dose) and DIZZINESS (still feeling dizzy). At the time of the report, DIZZINESS (very DIZZY), FALL (FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR), PHOTOPHOBIA (SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES), DRY MOUTH (Dry mouth), TASTE DISORDER (taste isn't the same after first dose), DIZZINESS (still feeling dizzy), PAIN (PAIN IN NECK, SHOULDER AND LOWER PACK), FATIGUE (VERY EXHAUSTED AND FELT VERY FATIGUE AND HAD TO TAKE A NAP) and INJECTION SITE PAIN (LOCAL PAIN IN THE INJECTION SITE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2021: No specific follow-up information recorded. On 30-Mar-2021: No specific follow-up information recorded.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Photophobia, Taste disorder
Clinical narrative: Dry mouth; taste isn't the same after first dose; still feeling dizzy; PAIN IN NECK, SHOULDER AND LOWER PACK; VERY EXHAUSTED AND FELT VERY FATIGUE AND HAD TO TAKE A NAP; LOCAL PAIN IN THE INJECTION SITE; very DIZZY; FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR; SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very DIZZY), FALL (FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR), PHOTOPHOBIA (SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES), DRY MOUTH (Dry mouth) and TASTE DISORDER (taste isn't the same after first dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Radiation therapy. Concurrent medical conditions included Penicillin allergy and Allergy to chemicals. Concomitant products included HYOSCYAMINE SULFATE (NULEV [HYOSCYAMINE SULFATE]) for Spasms, GLUCOSAMINE, CHONDROITIN, NAPROXEN SODIUM (ALEVE), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DIZZINESS (very DIZZY), FALL (FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR), PHOTOPHOBIA (SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES), PAIN (PAIN IN NECK, SHOULDER AND LOWER PACK), FATIGUE (VERY EXHAUSTED AND FELT VERY FATIGUE AND HAD TO TAKE A NAP) and INJECTION SITE PAIN (LOCAL PAIN IN THE INJECTION SITE). On an unknown date, the patient experienced DRY MOUTH (Dry mouth), TASTE DISORDER (taste isn't the same after first dose) and DIZZINESS (still feeling dizzy). At the time of the report, DIZZINESS (very DIZZY), FALL (FELL IN THE MIDDLE OF THE STREET AND ALMOST GOT HIT BY A CAR), PHOTOPHOBIA (SENSITIVE TO ANY SORT OF SUNLIGHT, LIGHT VERY HARSH ON HIS EYES), DRY MOUTH (Dry mouth), TASTE DISORDER (taste isn't the same after first dose), DIZZINESS (still feeling dizzy), PAIN (PAIN IN NECK, SHOULDER AND LOWER PACK), FATIGUE (VERY EXHAUSTED AND FELT VERY FATIGUE AND HAD TO TAKE A NAP) and INJECTION SITE PAIN (LOCAL PAIN IN THE INJECTION SITE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2021: No specific follow-up information recorded. On 30-Mar-2021: No specific follow-up information recorded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pain in extremity
Clinical narrative: Slight headache; Sweats; Still a little tender; Low grade fever; Chills; Exhaustion/ completely knocked down; Arm was more sore than after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was more sore than after the first dose), HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), PYREXIA (Low grade fever) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No recorded medical history). Concomitant products included METOPROLOL for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was more sore than after the first dose). On 08-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), PYREXIA (Low grade fever), CHILLS (Chills) and FATIGUE (Exhaustion/ completely knocked down). On 11-Feb-2021, the patient experienced HEADACHE (Slight headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Feb-2021, HYPERHIDROSIS (Sweats) outcome was unknown, PYREXIA (Low grade fever) and CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm was more sore than after the first dose), TENDERNESS (Still a little tender), FATIGUE (Exhaustion/ completely knocked down) and HEADACHE (Slight headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Pyrexia: 101.1 (Inconclusive) 101.1 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications reported included ellequist and metoprolol.     This case was linked to MOD-2021-043867 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tenderness
Clinical narrative: Slight headache; Sweats; Still a little tender; Low grade fever; Chills; Exhaustion/ completely knocked down; Arm was more sore than after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was more sore than after the first dose), HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), PYREXIA (Low grade fever) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No recorded medical history). Concomitant products included METOPROLOL for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was more sore than after the first dose). On 08-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats), TENDERNESS (Still a little tender), PYREXIA (Low grade fever), CHILLS (Chills) and FATIGUE (Exhaustion/ completely knocked down). On 11-Feb-2021, the patient experienced HEADACHE (Slight headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Feb-2021, HYPERHIDROSIS (Sweats) outcome was unknown, PYREXIA (Low grade fever) and CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm was more sore than after the first dose), TENDERNESS (Still a little tender), FATIGUE (Exhaustion/ completely knocked down) and HEADACHE (Slight headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Pyrexia: 101.1 (Inconclusive) 101.1 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications reported included ellequist and metoprolol.     This case was linked to MOD-2021-043867 (Patient Link).
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Thirst
Clinical narrative: feeling thirsty; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (feeling thirsty) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced THIRST (feeling thirsty). At the time of the report, THIRST (feeling thirsty) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications was not provided. No concomitant medications were provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: temperature of 100.4; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (temperature of 100.4) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (temperature of 100.4). At the time of the report, PYREXIA (temperature of 100.4) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 100.4 (High) temperature of 100.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pallor, Rash
Clinical narrative: the next two days I was very very pale and very very fatigued; After taking the first covid shot I developed a rash, not hives but a rash on my arms, some of my; I was completely wiped out/the next two days I was very very pale and very very fatigued; This spontaneous case was reported by a nurse and describes the occurrence of PALLOR (the next two days I was very very pale and very very fatigued), RASH (After taking the first covid shot I developed a rash, not hives but a rash on my arms, some of my) and FATIGUE (I was completely wiped out/the next two days I was very very pale and very very fatigued) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALLOR (the next two days I was very very pale and very very fatigued), RASH (After taking the first covid shot I developed a rash, not hives but a rash on my arms, some of my) and FATIGUE (I was completely wiped out/the next two days I was very very pale and very very fatigued). At the time of the report, PALLOR (the next two days I was very very pale and very very fatigued), RASH (After taking the first covid shot I developed a rash, not hives but a rash on my arms, some of my) and FATIGUE (I was completely wiped out/the next two days I was very very pale and very very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Pyrexia
Clinical narrative: super itchy almost to the touch in all her body; Headache; felt like she had fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (super itchy almost to the touch in all her body), HEADACHE (Headache) and PYREXIA (felt like she had fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included ZINC SULFATE MONOHYDRATE (YES 2 ZINC) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced PRURITUS (super itchy almost to the touch in all her body), HEADACHE (Headache) and PYREXIA (felt like she had fever). At the time of the report, PRURITUS (super itchy almost to the touch in all her body), HEADACHE (Headache) and PYREXIA (felt like she had fever) outcome was unknown.            No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspepsia, Flatulence, Headache
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of DYSPEPSIA (Indigestion), FLATULENCE (gas), PYREXIA (fever 100.4), CHILLS (cold chills) and MYALGIA (arm is very sore) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 13M2DA and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HCTZ and AMLODIPINE for an unknown indication.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DYSPEPSIA (Indigestion), FLATULENCE (gas), PYREXIA (fever 100.4), CHILLS (cold chills) and MYALGIA (arm is very sore). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (Indigestion), FLATULENCE (gas), PYREXIA (fever 100.4), CHILLS (cold chills), MYALGIA (arm is very sore) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 100.4 (High) had to go to ER last night due to fever 100.4. On 12-Feb-2021, Body temperature: 99.4 (High) Temperature is 99.4, took just before calling to customer care..         Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant follow up Event Headache was Received
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of DYSPEPSIA (Indigestion), FLATULENCE (gas), PYREXIA (fever 100.4), CHILLS (cold chills) and MYALGIA (arm is very sore) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 13M2DA and Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HCTZ and AMLODIPINE for an unknown indication.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced DYSPEPSIA (Indigestion), FLATULENCE (gas), PYREXIA (fever 100.4), CHILLS (cold chills) and MYALGIA (arm is very sore). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DYSPEPSIA (Indigestion), FLATULENCE (gas), PYREXIA (fever 100.4), CHILLS (cold chills), MYALGIA (arm is very sore) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 100.4 (High) had to go to ER last night due to fever 100.4. On 12-Feb-2021, Body temperature: 99.4 (High) Temperature is 99.4, took just before calling to customer care..         Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant follow up Event Headache was Received
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Chills, Decreased appetite, Diarrhoea
Clinical narrative: Can only eat a little; Pain in hand; She cant lift up her left arm; Vomiting; Pain in wrist; Arm started hurting; Shoulder felt like it was on fire to rib cage through collarbone down to hand; Temperature of 102; Shivers; Diarrhoea; Urinating a lot; Injection more in shoulderthan arm; A spontaneous report was received from consumer concerning a 70 year female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection was administered in shoulder more than arm (product administered at inappropriate site), arm started hurting (pain in arm) , shoulder felt like it was on fire to rib cage through collarbone down to hand (burning sensation), had temperature of 102 (pyrexia), shivers (chills), vomiting (vomiting), urinating a lot (urine output increased), diarrhea (diarrhea), pain in wrist (arthralgia) and hand (pain in hand), she cannot lift up her left arm (vaccination site movement impairment), and can only eat a little (decreased appetite),.  The patient's medical history included allergies. Concomitant product use was not reported.  On 02 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly for prophylaxis of COVID-19 infection in shoulder more than her arm. On 02 Mar 2021, same day of receiving vaccine, the patient experienced arm started hurting (pain in arm), shoulder felt like it was on fire to rib cage through collarbone down to hand, had temperature of 102, shivers, vomiting, urinating a lot, and diarrhea. On 03 Mar 2021, next day of receiving vaccine, the patient experienced pain in wrist, hand pain, unable to lift up her left arm, and she was only able to eat a little.  Treatment information was not provided.  Action taken with mRNA-1273 with respect to the events was not reported.  The outcome of the event, vaccine administered at inappropriate site was considered resolved and for the remaining events, it was not reported.  The reporter did not provide the causality assessment for the events.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This report also refers to a case of product administered at inappropriate site for mRNA-1273 (lot # unknown), with no associated AEs. Further information has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product administered at inappropriate site, Pyrexia, Urine output increased, Vaccination site movement impairment
Clinical narrative: Can only eat a little; Pain in hand; She cant lift up her left arm; Vomiting; Pain in wrist; Arm started hurting; Shoulder felt like it was on fire to rib cage through collarbone down to hand; Temperature of 102; Shivers; Diarrhoea; Urinating a lot; Injection more in shoulderthan arm; A spontaneous report was received from consumer concerning a 70 year female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection was administered in shoulder more than arm (product administered at inappropriate site), arm started hurting (pain in arm) , shoulder felt like it was on fire to rib cage through collarbone down to hand (burning sensation), had temperature of 102 (pyrexia), shivers (chills), vomiting (vomiting), urinating a lot (urine output increased), diarrhea (diarrhea), pain in wrist (arthralgia) and hand (pain in hand), she cannot lift up her left arm (vaccination site movement impairment), and can only eat a little (decreased appetite),.  The patient's medical history included allergies. Concomitant product use was not reported.  On 02 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly for prophylaxis of COVID-19 infection in shoulder more than her arm. On 02 Mar 2021, same day of receiving vaccine, the patient experienced arm started hurting (pain in arm), shoulder felt like it was on fire to rib cage through collarbone down to hand, had temperature of 102, shivers, vomiting, urinating a lot, and diarrhea. On 03 Mar 2021, next day of receiving vaccine, the patient experienced pain in wrist, hand pain, unable to lift up her left arm, and she was only able to eat a little.  Treatment information was not provided.  Action taken with mRNA-1273 with respect to the events was not reported.  The outcome of the event, vaccine administered at inappropriate site was considered resolved and for the remaining events, it was not reported.  The reporter did not provide the causality assessment for the events.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This report also refers to a case of product administered at inappropriate site for mRNA-1273 (lot # unknown), with no associated AEs. Further information has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Can only eat a little; Pain in hand; She cant lift up her left arm; Vomiting; Pain in wrist; Arm started hurting; Shoulder felt like it was on fire to rib cage through collarbone down to hand; Temperature of 102; Shivers; Diarrhoea; Urinating a lot; Injection more in shoulderthan arm; A spontaneous report was received from consumer concerning a 70 year female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection was administered in shoulder more than arm (product administered at inappropriate site), arm started hurting (pain in arm) , shoulder felt like it was on fire to rib cage through collarbone down to hand (burning sensation), had temperature of 102 (pyrexia), shivers (chills), vomiting (vomiting), urinating a lot (urine output increased), diarrhea (diarrhea), pain in wrist (arthralgia) and hand (pain in hand), she cannot lift up her left arm (vaccination site movement impairment), and can only eat a little (decreased appetite),.  The patient's medical history included allergies. Concomitant product use was not reported.  On 02 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly for prophylaxis of COVID-19 infection in shoulder more than her arm. On 02 Mar 2021, same day of receiving vaccine, the patient experienced arm started hurting (pain in arm), shoulder felt like it was on fire to rib cage through collarbone down to hand, had temperature of 102, shivers, vomiting, urinating a lot, and diarrhea. On 03 Mar 2021, next day of receiving vaccine, the patient experienced pain in wrist, hand pain, unable to lift up her left arm, and she was only able to eat a little.  Treatment information was not provided.  Action taken with mRNA-1273 with respect to the events was not reported.  The outcome of the event, vaccine administered at inappropriate site was considered resolved and for the remaining events, it was not reported.  The reporter did not provide the causality assessment for the events.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This report also refers to a case of product administered at inappropriate site for mRNA-1273 (lot # unknown), with no associated AEs. Further information has been requested.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Site of injection is sore; fever(100.9F); This spontaneous case was reported by an other caregiver and describes the occurrence of VACCINATION SITE PAIN (Site of injection is sore) and PYREXIA (fever(100.9F)) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Site of injection is sore) and PYREXIA (fever(100.9F)). At the time of the report, VACCINATION SITE PAIN (Site of injection is sore) and PYREXIA (fever(100.9F)) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was reported by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: patients Contact info Email added
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased
Clinical narrative: Blood sugar level higher than normal (340); This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)). At the time of the report, BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient's insulin bomb is not enough for keeping the blood sugar level normalized. Patient is using extra injected insulin. Concomitant medications details were not reported by the reporter. Treatment Details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Rash
Clinical narrative: Generally feeling unwell; Rash; Chills; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MALAISE (Generally feeling unwell), RASH (Rash) and CHILLS (Chills) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Generally feeling unwell), RASH (Rash) and CHILLS (Chills). At the time of the report, MALAISE (Generally feeling unwell), RASH (Rash) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin discolouration, Urticaria
Clinical narrative: blocky spots; terrible itch; hives; This spontaneous case was reported by a non-health professional and describes the occurrence of SKIN DISCOLOURATION (blocky spots), PRURITUS (terrible itch) and URTICARIA (hives) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 61620A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced SKIN DISCOLOURATION (blocky spots), PRURITUS (terrible itch) and URTICARIA (hives). At the time of the report, SKIN DISCOLOURATION (blocky spots), PRURITUS (terrible itch) and URTICARIA (hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       There is no concomitant details provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: balancing; like all around moving; little tired; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (balancing), VERTIGO (like all around moving), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). On 03-Mar-2021, the patient experienced BALANCE DISORDER (balancing), VERTIGO (like all around moving) and FATIGUE (little tired). The patient was treated with PARACETAMOL (TYLENOL) for Fever chills and Headache, at an unspecified dose and frequency. At the time of the report, BALANCE DISORDER (balancing), VERTIGO (like all around moving), CHILLS (chills), PYREXIA (fever), HEADACHE (headache) and FATIGUE (little tired) outcome was unknown.            Concomitant medications details were not reported by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: balancing; like all around moving; little tired; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (balancing), VERTIGO (like all around moving), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). On 03-Mar-2021, the patient experienced BALANCE DISORDER (balancing), VERTIGO (like all around moving) and FATIGUE (little tired). The patient was treated with PARACETAMOL (TYLENOL) for Fever chills and Headache, at an unspecified dose and frequency. At the time of the report, BALANCE DISORDER (balancing), VERTIGO (like all around moving), CHILLS (chills), PYREXIA (fever), HEADACHE (headache) and FATIGUE (little tired) outcome was unknown.            Concomitant medications details were not reported by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Nausea
Clinical narrative: waves of dizziness; loss of appetite; Nausea; is very tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (waves of dizziness), DECREASED APPETITE (loss of appetite), NAUSEA (Nausea) and FATIGUE (is very tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIZZINESS (waves of dizziness), DECREASED APPETITE (loss of appetite), NAUSEA (Nausea) and FATIGUE (is very tired). On 05-Mar-2021, DIZZINESS (waves of dizziness), DECREASED APPETITE (loss of appetite), NAUSEA (Nausea) and FATIGUE (is very tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Updated outcome of events from Unknown to Recovered/Resolved
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: arm is killing patient; fever of 100.6 degrees; achiness; joint pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is killing patient), PYREXIA (fever of 100.6 degrees), MYALGIA (achiness), ARTHRALGIA (joint pain) and FATIGUE (fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm is killing patient), PYREXIA (fever of 100.6 degrees), MYALGIA (achiness), ARTHRALGIA (joint pain) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (arm is killing patient), PYREXIA (fever of 100.6 degrees), MYALGIA (achiness), ARTHRALGIA (joint pain) and FATIGUE (fatigue) outcome was unknown.            The action taken with mRNA -1273 in response to the event was not applicable. No concomitant medication information was provided. The patients treatment product information included tylenol.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (Diarrhea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Diabetes and Acid reflux (oesophageal). Concomitant products included GABAPENTIN and AMITRIPTYLINE HYDROCHLORIDE (ELAVIL [AMITRIPTYLINE HYDROCHLORIDE]) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient take Pepto Bismol for Treatment medication.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: NNI
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash, Rash pruritic, Urticaria, Vaccination site rash
Clinical narrative: redness; hives; rash on back and clavicle; (rash) very itchy; Rash at the injection site in the left arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (redness), URTICARIA (hives), RASH (rash on back and clavicle), RASH PRURITIC ((rash) very itchy) and VACCINATION SITE RASH (Rash at the injection site in the left arm) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Benign prostatic hyperplasia. Concomitant products included AMLODIPINE for Blood pressure management, TADALAFIL for Enlarged prostate.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), URTICARIA (hives), RASH (rash on back and clavicle), RASH PRURITIC ((rash) very itchy) and VACCINATION SITE RASH (Rash at the injection site in the left arm). At the time of the report, ERYTHEMA (redness) and VACCINATION SITE RASH (Rash at the injection site in the left arm) outcome was unknown and URTICARIA (hives), RASH (rash on back and clavicle) and RASH PRURITIC ((rash) very itchy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Benadryl, Steroid Ointment and Body Wash.   This case was linked to MOD-2021-037010 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up information was received: Added Patient Demographics, Reporter Information, Medical History Information, Concomitant and Treatment Medications, Events associated with vaccine.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Chills, Fatigue, Headache
Clinical narrative: numbness in mouth; tingling in fingers/toes; pain in feet; loss of taste; muscle pain; joint pain; fatigue; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (numbness in mouth), PARAESTHESIA (tingling in fingers/toes), PAIN IN EXTREMITY (pain in feet), AGEUSIA (loss of taste) and MYALGIA (muscle pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 21-Dec-2020. Concurrent medical conditions included Food allergy, Drug allergy (Hydrocodone allergy, Inderal allergy), High cholesterol, Diabetes, Blood pressure high, Atrial fibrillation and Prostate examination abnormal (prostate issues unspecified). Concomitant products included METFORMIN, PRAVASTATIN, LISINOPRIL, SOTALOL, RIVAROXABAN (XARELTO) and FINASTERIDE for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (chills). On 12-Feb-2021, the patient experienced HYPOAESTHESIA ORAL (numbness in mouth), PARAESTHESIA (tingling in fingers/toes), PAIN IN EXTREMITY (pain in feet) and AGEUSIA (loss of taste). At the time of the report, HYPOAESTHESIA ORAL (numbness in mouth), PARAESTHESIA (tingling in fingers/toes), PAIN IN EXTREMITY (pain in feet), AGEUSIA (loss of taste), MYALGIA (muscle pain), ARTHRALGIA (joint pain), FATIGUE (fatigue), HEADACHE (headache) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Dec-2020, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication not reported.